Preview

Genentech Case Study

Good Essays
Open Document
Open Document
564 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Genentech Case Study
Overview:

Genentech Company is facing a lot of problems and difficulties in order to implement and incorporate best technologies for future growth regarding uncertain future of its cancer drugs. The senior vice president of product David Ebersman along with his team is busy outlining the best approach to it.

Central Issue:

What measures should Genentech employ or implement in order to increase their production and manufacturing capacity to meet the future anticipated and predicted demands over the next 2 to 3 years for a family of new cancer drug?

Recommended courses of action:

They should try to further improve the current process by boosting throughput.

Try to build relationships with other manufacturers and additional companies to meet the Excess demands by negotiating contracts and agreements.

Start searching for economical and strategic locations for building up of new manufacturing plant. It’s important to keep looking for space and be ready with a blue print of an additional facility.

Try to stay away from messing up with FDA regulations by avoiding long period revalidation.

Focus should be laid on fully completing the CCP2 at Vacaville.

Basis for recommendations:

There is no proper assurance of a continuous growth and increase in sales by creating the CCP3 facility. The investment on implementing CCP3 is worth $600 million. And it is still not clear about the effectiveness and market response of Avastin. The drug could also result in failure and by investing CCP3 will surely cost us $6oo million. The golden rule for the moment is to wait and watch as sales are dependent on market response and there is point investing $600 million with hinting success.

Moreover, the location at Vacaville won’t be able to withstand the additional load of CCP3, if we built it on the same location alongside CCP2, which is not fully completed. The process and work force will be at risk of mounted pressure and in turn new employees that might

You May Also Find These Documents Helpful

  • Satisfactory Essays

    The BIOPHARM

    • 743 Words
    • 3 Pages

    Sell the plant to Biopharm as they will keep operating it as a pharmaceutical company to preserve our current workforce which will save the company 1million.…

    • 743 Words
    • 3 Pages
    Satisfactory Essays
  • Good Essays

    Merck Case

    • 587 Words
    • 4 Pages

    1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop drugs?…

    • 587 Words
    • 4 Pages
    Good Essays
  • Good Essays

    In order for this new location, Hangzhou, to be profitable, Riordan Manufacturing will need a strategic capacity plan which will provide an approach for determining the overall capacity level of capital-intensive resources—facilities, equipment, and overall labor force size—that best supports the company’s long-range competitive strategy (Chase, Jacobs, & Aquilano, 2006). The capacity level has a critical impact on the Hangzhou location. If capacity is inadequate, Riordan may lose customers through slow service or by allowing competitors to enter the market (Chase, Jacobs, & Aquilano, 2006). If capacity is excessive, they may have to reduce prices to stimulate demand; underutilize its workforce; carry excess inventory; or seek additional, less profitable products to stay in business (Chase, Jacobs, & Aquilano, 2006).…

    • 1034 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    Procurement: The company has a strong focus on cultivating a diverse supplier pool in order to maximize quality and talent available to Genentech, which gives the company access to unique outside resources.…

    • 1305 Words
    • 6 Pages
    Powerful Essays
  • Satisfactory Essays

    Gm 533 Statistics

    • 284 Words
    • 2 Pages

    The company management has decided to market this product if the expected contribution to profit for the next six months is more than $90,000. Based on the information given above, should the company begin manufacturing the new drug?…

    • 284 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    The significant resource that led to Genentech 's competitive advantage was culture. This culture was instilled by it 's founding partners Robert Swanson and Herbert Boyer. In this culture R&D focused on applying leading edge scientific knowledge to discover and develop best-in-class medicines. The culture of "individual creativity and initiative," helped to establish a reputation that attracted some of the best scientists in the world who were encouraged not only to work on projects associated with the companies goals, but also to work on projects that piqued their own interests. The overall culture led to a highly productive environment labeled by insiders as "casual intensity."…

    • 1095 Words
    • 4 Pages
    Satisfactory Essays
  • Better Essays

    Nucleon Case

    • 1217 Words
    • 5 Pages

    Although we see the benefit to investing in having their own production capability in house, we feel that in the short-term, Nucleon should not overextend itself on its very first drug venture before it is sure that it will be on the fast track to FDA approval. Furthermore, Nucleon would have to deal with the difficulty and costs of procuring the right talent to fill all the holes that will open up in its organizational structure with regards to maintenance, procurement, quality assurance, technical support, logistics, and other functions in order to operate the manufacturing plant.…

    • 1217 Words
    • 5 Pages
    Better Essays
  • Satisfactory Essays

    Adneux case study

    • 362 Words
    • 2 Pages

    As an emerging private biotechnology company, Adnexus Therapeutics Inc faces not only the pressure from those established big companies but also obstacles in gathering enough fund. Based on such situation, Dr. John Mendlein strongly recommended that the company find a partner with sufficient monetary and expertise resources. That’s where BMS appeared, showing great interest in ATI’s invention and the cooperation programme. Now the ATI achieved great progress and the future seems promising. BMS becomes more and more serious about purchasing the company’s outright. However, whether to keep the collaborative partnership or to pursuit independent development is hard for ATI to decide. What’s more, the next emphasis on Angiocept or Adnectins reamins unknown.…

    • 362 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Tamiflu Case

    • 3403 Words
    • 14 Pages

    This expansion in manufacturing capacity has increased production of the drug to over 400 million treatments annually —…

    • 3403 Words
    • 14 Pages
    Powerful Essays
  • Better Essays

    Genzyme Case Study

    • 894 Words
    • 4 Pages

    Henri Termeer started Genzyme Corporation with ten employees and then grew it to a corporation that now has four billion in sales per year. Genzyme is a biotechnology company that specializes in finding orphan drugs, which specifically cure enzyme deficiency conditions. To offer a brief explanation, an orphan drug is a pharmaceutical agent developed to cure a rare, orphan, disease. In order to find the cures for these rare diseases, technology using living biological systems and living organisms is used, which is known as biotechnology. In order for a biotechnology firm to succeed time is needed to give the firm the opportunity to find a successful product. According to Mr. Termeer, this requires that upon investing in a biotechnology firm you wait for results and the investment is long term.…

    • 894 Words
    • 4 Pages
    Better Essays
  • Good Essays

    Mitel Analysis

    • 1429 Words
    • 6 Pages

    In order to obtain the management goal, we need to expand our production capacity. Four options are available to increase capacity, and they will be evaluated by the following factors:…

    • 1429 Words
    • 6 Pages
    Good Essays
  • Satisfactory Essays

    Identification of metrics is a fundamental component of measuring the effectiveness of a business plan or a strategic plan. Metrics help organizations understand the current business climate, the competitive positioning and assists in planning. I did not realize the level of difficulty in the selection of metric until thinking about which…

    • 443 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Pharmaceutical companies spend a lot of time in developing and manufacturing drugs. One type of drug could take ten to twenty years after testing the drug, being approved by the FDA, and distribution. Makes one wonder just how much money they put into the discovery of…

    • 627 Words
    • 3 Pages
    Good Essays
  • Better Essays

    Merck & Co

    • 1066 Words
    • 5 Pages

    1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop a new drug?…

    • 1066 Words
    • 5 Pages
    Better Essays
  • Powerful Essays

    Genentech

    • 2820 Words
    • 12 Pages

    What gets a company to be ranked as part of the 100 Best Places to Work? There are many different areas that are studied to include pay, health benefits, work-life, and perks. So what put Genentech on the radar and kept them there, you ask? Genentech offers a six-week fully paid sabbatical every six years of employment. That is not the only perk but a fully paid sabbatical is one that has stuck out among many employees.…

    • 2820 Words
    • 12 Pages
    Powerful Essays